R&D News | pharmaphorum

News

Anthos hails win over Xarelto with novel anticoagulant

Anthos Therapeutics says a phase 2b trial of its factor XI inhibitor anticoagulant abelacimab has been stopped early due to an “overwhelming” reduction in bleeding complic

News

US researchers start trials of universal flu vaccine

Researchers at the National Institutes of Health (NIH) have started dosing patients in a phase 1 trial of a new influenza vaccine candidate that aims to sidestep the annua

News

Scientists find elusive cause of cell death in Alzheimer's

Researchers think they have worked out how neurons die off in Alzheimer's disease, a question that has gone unanswered for decades, opening new avenues for research and a

News

Double IPOs headline this week's biotech financings

This week saw two $250 million-plus initial public offering (IPO) filings for Neumora Therapeutics and RayzeBio, plus a record third-round financing for Generate Biomedici

News

AlveoGene debuts to develop inhaled gene therapy technology

Today saw the debut of a new UK-based biotech, called AlveoGene, which has been formed to develop therapies based on a lentiviral vector platform used to deliver gene ther

News

UK trial will test digital tinnitus therapy from Oto

Just over a year after completing a seed financing round, digital health company Oto has launched a trial of its mobile app that aims to support people with tinnitus, a di

Anthos hails win over Xarelto with novel anticoagulant

US researchers start trials of universal flu vaccine

Scientists find elusive cause of cell death in Alzheimer's

Double IPOs headline this week's biotech financings

AlveoGene debuts to develop inhaled gene therapy technology

UK trial will test digital tinnitus therapy from Oto

Pharvaris plans filings for HAE drug after pivotal trial win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks